Skip to main content
. 2010 Apr 20;7(2):72–81. doi: 10.7150/ijms.7.72

Figure 5.

Figure 5

Cytotoxicity assay of MLPC cells against leukemia cells expressing WT1 intrinsically. A CFSE-labeled target cytotoxicity assay was performed by using cells cultured in each well of MLPC for 2 weeks as effector cells and a CML blastic crisis cell line expressing HLA-A*2402, C2F8, as target cells at effector : target ratio of 5:1. MLPC was initiated by using MNCs of PB drawn from a CML patient at 3 weeks after the 2nd administration of WT1 peptide vaccination.